Winter's drop in temperatures, combined with low humidity and indoor heating, can strip the skin of moisture and cause dryness and cracking. However, making a few simple changes to your daily skin care routine in the winter months can help offset this problem.
Thanks to the demand for longer-lasting treatments for aging skin with little downtime, new soft tissue fillers that are approved by the U.S. Food and Drug Administration (FDA) "“ or close to receiving FDA approval "“ are making headlines as viable options for those who want to turn back the hands of time.
A typical day at the beach might cost the average beachgoer little more than the cost of parking and lunch for endless hours of sun and surf. But a study finds that for those who end up with a bad sunburn at the end of the day, the cost could rise dramatically "“ for themselves and their employers.
Regular visits to nail salons cost consumers more than six billion dollars each year. Consumers also spend millions on retail nail cosmetics. While the number of problems associated with nail cosmetics and services is small, there are some health risks associated with all that soaking, buffing, massaging and polishing.
Studies have shown that adopting a comprehensive sun protection program can substantially lower skin cancer risk. However, the most common form of sun protection "“ sunscreen "“ remains the subject of heated controversy due to a number of public health questions currently under debate.
Surgeons have been able to strip tiny blood vessels from rats and re-engineer them to be more effective when implanted in a new animal. The findings could benefit people who need blood vessels for vascular bypass surgery.
Scientists have identified a gene that controls the amazing ability of adult stem cells to self-renew, or make new copies of themselves, throughout life.
Surgeons have had mixed success in growing new human jawbones after radiation therapy for head and neck cancer. Researchers are studying rats to determine how and why distraction osteogenesis works and have found clues to the uneven clinical results.
David Kissane, M.D. has been named Chairman of the Department of Psychiatry and Behavioral Sciences at Memorial Sloan-Kettering Cancer Center (MSKCC).
Medical College of Wisconsin researchers identify Inflammatory Bowel Disease as an equal opportunity condition.
Hypnotherapy seems to be an effective long term treatment for irritable bowel syndrome (IBS), lasting for "at least five years," conclude researchers.
Cabin crew seem to be at increased risk of breast and skin cancers, suggests research.
Fewer than 20 percent of adults can correctly identify the signs of stroke and know to call 911 in the case of acute stroke events, according to a new study.
A new anti-cancer agent designed to block the signals responsible for telling cancer cells to grow has shown promising results for patients with advanced non-small cell lung cancer. A subset of the data from this clinical trial formed the basis for approval of the drug by the FDA.
In a recent study of children with inflammatory bowel disease, researchers have found that children with IBD have significantly more, and more frequent, eating behavior problems than healthy kids, and gender differences in weight and body image contribute to the behaviors.
The American Pharmacists Association applauds the Washington Post on its ground-breaking investigative series ("Pharmaceutical Roulette: A Vast, Unregulated Shadow Market") on threats to the U.S. prescription drug system, appearing during National Pharmacy Week (October 19-25).
Researchers have developed novel methods to test the nerve-muscle function using micromanometric catheters (which record pressures generated by muscles in the bowel wall) to enable them to study the swallowing mechanisms in premature infants.
The American Academy of Dermatology will host DERM UPDATE 2003, Protecting What Protects YouSM, its annual National Healthy Skin Program media briefings. All media are invited to attend as eight speakers present information on the latest advances in treating dermatologic conditions.
GlaxoSmithKline today announced that the FDA has granted marketing clearance for Lexivaâ„¢ (fosamprenavir calcium) (Lex-ee'-va, formerly GW433908, or 908), a new protease inhibitor (PI) for the treatment of HIV infection in adults in combination with other antiretroviral medications.
A highly precise, focused type of radiation therapy is effective in treating localized, low-grade brain tumors in children as young as two, according to a new study.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right